Evidence map›Paper›PMID 37237318›Full record

ArticlePilot and feasibility studies2023

The diabetes insulin self-management education (DIME) intervention for people with type 2 diabetes starting insulin: a pilot feasibility randomised controlled trial.

Kirsty Winkley, Taru Sorsa, Qingxiu Tian, Ilse Reece, Christina Fitzgerald, Mark Chamley, Khalida Ismail, Angus Forbes, Rebecca Upsher

Open access · goldAbstract read
In one paragraph

Article in Pilot and feasibility studies, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Kirsty WinkleyFlorence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King's College London, SE1 8WA, London, UK. kirsty.winkley@kcl.ac.uk.ORCID http://orcid.org/0000-0002-1725-6040
Taru SorsaInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Qingxiu TianDepartment of Endocrinology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Ilse ReeceLambeth Diabetes Intermediate Care Team, London, UK.
Christina FitzgeraldLambeth Diabetes Intermediate Care Team, London, UK.
Mark ChamleyLambeth Diabetes Intermediate Care Team, London, UK.
Khalida IsmailInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Angus ForbesFlorence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King's College London, SE1 8WA, London, UK.
Rebecca UpsherInstitute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
King's College London · GBLambeth Hospital · GBShandong Provincial QianFoShan Hospital · CN

Funding

National Institute for Health Research NIHR ICA-SCL-2015-01-002
6 · The paper itself

Abstract

objectiveTo determine the feasibility and acceptability of a diabetes insulin self-management education (DIME) group intervention for people with type 2 diabetes starting insulin.

designSingle-centre parallel randomised pilot trial.

settingPrimary care, South London, UK. SUBJECTS: Adults with type 2 diabetes, requiring insulin treatment, on maximum tolerated dose of 2 or more oral antidiabetic drugs with HbA1c > / = 7.5% (58 mmol/mol) on 2 occasions. We excluded people who were non-fluent in English; morbid obesity (BMI > / = 35 kg/m

methodsParticipants were randomised using blocks of 2 or 4 to 3, 2-h group, face-to-face, DIME sessions or standard insulin group education sessions (control). We assessed feasibility according to consent to randomisation and attendance at intervention (DIME) and standard group insulin education sessions. Acceptability of the interventions was determined using exit interviews. We additionally measured change in self-reported insulin beliefs, diabetes distress and depressive symptoms between baseline and 6-month post-randomisation.

resultsThere were 28 potentially eligible participants, of which 17 consented to randomisation, 9 were allocated to the DIME group intervention and 8 were allocated to the standard group insulin education. Three people withdrew from the study (1 from DIME and 2 from standard insulin education) before the start of the first session and did not complete baseline questionnaires. Of the remaining participants (n = 14), all DIME participants (n = 8) completed all 3 sessions, and all standard insulin education participants (n = 6) completed at least 1 standard insulin education session. The median group size was 2, the mean age of participants was 57.57 (SD 6.45) years, and 64% were female (n = 9). Exit interviews demonstrated that all participants (n = 7) found the group sessions acceptable, and thematic analysis of interview transcripts indicated social support, the content of group sessions and post-group experiences were positive, especially amongst DIME participants. There was improvement on self-report questionnaires.

conclusionsThe DIME intervention was acceptable and feasible to deliver to participants with type 2 diabetes starting insulin in South London, UK.

trial registrationInternational Study Registration Clinical Trial Network (ISRCTN registration number 13339678).

Indexed as

Diabetes self-managementInsulinInterventionPilot studyType 2 diabetes

Identifiers

PMID37237318
PMCPMC10213567
OpenAlexW4378473015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.